Company intelligence / Profile preview

Aspect Biosystems

Vancouver, British Columbia, Canadaaspectbiosystems.com ↗

Ownership: Private
Employees: ~100
Development stage: Preclinical

Overview

Aspect Biosystems is developing bioprinted tissue therapeutics that are designed to replace, repair, or supplement biological function in the body. The company is advancing its pipeline toward clinical evaluation, with a focus on metabolic indications including pancreatic tissue for type 1 diabetes and liver tissue for various disorders.

Therapeutic areas: GastroenterologyEndocrinology
Modalities: Bioprinted tissue therapeuticscell therapies
Industry: Biotech

Partnerships

Novo NordiskGlaxoSmithKlineMerckJSR

Beyond the preview

Go deeper on Aspect Biosystems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aspect Biosystems.

Explore the full profile